Valuation: Virbac

Capitalization 2.67B 3.09B 2.52B 2.28B 4.21B 265B 4.74B 29.22B 11.41B 122B 11.6B 11.36B 444B P/E ratio 2025 *
16.8x
P/E ratio 2026 * 15x
Enterprise value 2.78B 3.21B 2.61B 2.36B 4.37B 275B 4.93B 30.36B 11.85B 126B 12.05B 11.8B 462B EV / Sales 2025 *
1.87x
EV / Sales 2026 * 1.73x
Free-Float
47.73%
Yield 2025 *
0.5%
Yield 2026 * 0.55%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.41%
1 week-3.38%
Current month-5.56%
1 month+2.14%
3 months+3.62%
6 months-2.48%
Current year-0.63%
More quotes
1 week 313.5
Extreme 313.5
328.5
1 month 301.5
Extreme 301.5
335.5
Current year 249.7
Extreme 249.7
335.5
1 year 249.7
Extreme 249.7
400
3 years 215
Extreme 215
400
5 years 176.4
Extreme 176.4
448.5
10 years 102.1
Extreme 102.1
448.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 49 2024-09-26
Chief Operating Officer - 2023-06-30
Chief Tech/Sci/R&D Officer - 2020-12-31
Director TitleAgeSince
Chairman 60 2006-03-31
Director/Board Member 66 2010-07-27
Director/Board Member 64 2017-09-04
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.41%-3.38%-8.31%-6.81% 3.09B
+1.50%+0.12%-4.00%+4.54% 75.16B
-0.70%+5.51%-20.75%-36.37% 7.04B
-0.10%+1.15%-2.43%-3.21% 3.61B
-3.92%-2.48%+18.63%-24.50% 2.31B
-0.94%-5.58%+44.04%+27.32% 1.34B
-2.87%-3.77%+5.00%-23.71% 1.07B
+0.43%+1.29%-14.70%-41.44% 1.01B
-0.55%-0.14%-28.92%-35.95% 995M
+0.49%+2.60%+37.85%+31.28% 993M
Average -0.81%+0.32%+2.64%-10.89% 9.66B
Weighted average by Cap. +0.93%+0.37%-3.93%-0.41%
See all sector performances

Financials

2025 *2026 *
Net sales 1.48B 1.72B 1.4B 1.26B 2.34B 147B 2.63B 16.22B 6.33B 67.53B 6.44B 6.3B 247B 1.56B 1.8B 1.47B 1.33B 2.46B 155B 2.77B 17.05B 6.66B 71B 6.77B 6.63B 259B
Net income 162M 187M 152M 138M 255M 16.02B 287M 1.77B 690M 7.36B 702M 687M 26.89B 179M 207M 169M 153M 282M 17.77B 318M 1.96B 765M 8.16B 778M 762M 29.82B
Net Debt 104M 120M 97.97M 88.65M 164M 10.31B 185M 1.14B 444M 4.74B 452M 442M 17.31B 18.13M 20.98M 17.07M 15.44M 28.57M 1.8B 32.18M 198M 77.42M 826M 78.71M 77.05M 3.02B
More financial data * Estimated data
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (61.6%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (38.4%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (40.8%), Latin America (15.9%), North America (13%), India/Africa/Middle East (12.5%), East Asia (10.1%) and Pacific (7.7%).
Employees
6,365
More about the company
Date Price Change Volume
25-06-13 314.50 -1.41% 171
25-06-12 319.00 -0.16% 3,573
25-06-11 319.50 -1.39% 3,883
25-06-10 324.00 -0.61% 1,836
25-06-09 326.00 +0.15% 1,556

Real-time Euronext Paris, June 13, 2025 at 03:00 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
319.00EUR
Average target price
386.83EUR
Spread / Average Target
+21.26%
Consensus

Quarterly revenue - Rate of surprise